Faculty who have authored publication A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors.
| Name | Title | Department | Institution |
|---|---|---|---|
| Razelle Kurzrock MD | Center Associate Director, Professor | Medicine | Medical College of Wisconsin |
